Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug

International Journal of Pharmaceutics

Volumn 352, Issue 1-2, 2008, Pages 36-43

  Fujioka, Yoshitsugu ^a   Metsugi, Yukiko ^a   Ogawara, Ken ichi ^a   Higaki, Kazutaka ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Biopharmaceutics classification system class II; Cecum arriving time; Gastric emptying; Griseofulvin; In vivo dissolution; Intestinal transit

Indexed keywords

AMINOPHYLLINE; GRISEOFULVIN; SALAZOSULFAPYRIDINE; SULFAPYRIDINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CECUM; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG SOLUBILITY; GASTROINTESTINAL TRANSIT; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING;

ADMINISTRATION, ORAL; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CECUM; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; GRISEOFULVIN; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALE; MODELS, BIOLOGICAL; POWDERS; RATS; RATS, WISTAR; SOLUBILITY; SULFAPYRIDINE; THEOPHYLLINE;

EID: 39449086202     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.10.008     Document Type: Article

References (37)

1. Abrahamsson B., Alpsten M., Hugosson M., Jonsson U.L.F.E., Sundgren A., and Tolli J. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets. Pharm. Res. 10 (1993) 709-714
2. Amidon G.L., Doo-Man O., and Curl R.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 10 (1993) 264-270
3. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
4. Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Tamaki N., Kamimura H., Katougi Y., and Omi Y. Bioavailability of griseofulvin from tablets in beagle dogs and correlation rate and bioavailability in humans. J. Pharm. Sci. 71 (1982) 1169-1172
5. Bates T.R., and Carrigan P.J. Apparent absorption kinetics of micronized griseofulvin after its oral administration on single and multiple-dose regiments to rats as a corn oil-in-water emulsion and aqueous suspension. J. Pharm. Sci. 64 (1975) 1475-1481
6. Castiglione K.F., Read N.W., and French S.J. Food intake responses to upper gastrointestinal lipid infusions in humans. Physiol. Behav. 64 (1998) 141-145
7. Davis S.S., Hardy J.G., and Fara J.W. Transit of pharmaceutical dosage forms thought the small intestine. Gut 27 (1986) 886-892
8. Davis S.S., Stockwell A.F., Taylor M.J., Hardy J.G., Whalley D.R., Wilson C.G., Bechgaard H., and Christensen F.N. The effect of density on the gastric emptying of single- and multiple-unit dosage forms. Pharm. Res. 3 (1986) 208-213
9. Devereux J.E., Newton J.M., and Short M.B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol. 42 (1990) 500-501
10. Dobson C.L., Davis S.S., Chauhan S., Sparrow R.A., and Wilding I.R. The effect of ileal break activators on the oral bioavailability of atenolol in man. Int. J. Pharm. 248 (2002) 61-70
11. Dressman J.B., and Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11 suppl. (2000) S73-S80
12. Emara L.H., Badr R.M., and Elbary A.A. Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers. Drug Dev. Ind. Pharm. 28 (2002) 795-807
13. Fujioka Y., Kadono K., Fujie Y., Metsugi Y., Ogawara K., Higaki K., and Kimura T. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in vitro dissolution study. J. Control. Release 119 (2007) 222-228
14. Hägermark O., Berlin A., Wallin I., and Boréus O.L. Plasma concentrations of griseofulvin in healthy volunteers and out-patients treated for onychomycosis. Acta Dermatovener. 56 (1976) 289-296
15. Haruta S., Iwasaki N., Ogawara K., Higaki K., and Kimura T. Absorption behavior of orally administration drugs in rats treated with propantheline. J. Pharm. Sci. 87 (1998) 1081-1085
16. Heading R.C., Nimmo J., Prescott L.F., and Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br. J. Pharmacol. 47 (1973) 415-421
17. Higaki K., Yamashita S., and Amidon G.L. Time-dependent oral absorption models. J. Pharmacokin. Pharmacodyn. 28 (2001) 109-128
18. Jamali F., and Axelson J.E. Influence of metoclopramide and propantheline on GI absorption of griseofulvin in rats. J. Pharm. Sci. 66 (1977) 1540-1543
19. Kadono K., Yokoe J., Ogawara K., Higaki K., and Kimura T. Analysis and prediction of absorption behavior for theophylline orally administered as powders based on gastrointestinal-transit-absorption (GITA) model. Drug Metab. Pharmacokinet. 17 (2002) 307-315
20. Kellow J.E., Borody T.J., Phillips S.F., Haddad A.D., and Brown M.L. Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit. Gastroenterology 91 (1986) 396-400
21. Khan A.K.A., Truelove S.C., and Aronson J.K. The disposition and metabolism of sulphasalazine (salicylazosulfapyridine) in man. Br. J. Clin. Pharmacol. 13 (1980) 523-528
22. Kimura T., and Higaki K. Gastrointestinal transit and drug absorption. Biol. Pharm. Bull. 25 (2002) 149-164
23. Lipka E., Lee I.-D., Langguth P., Spahn-Langguth H., Mutschler E., and Amidon G.L. Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability date obtained in dogs. J. Pharmacokinet. Biopharm. 23 (1995) 267-286
24. Loo J.C.K., and Riegelman S. New method for calculating the intrinsic absorption rate of drugs. J. Pharm. Sci. 57 (1968) 918-928
25. Mizuta H., Kawazoe Y., and Ogawa K. Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog. Chem. Pharm. Bull. 38 (1990) 2810-2813
26. Peh K.K., and Yuen K.H. Indirect gastrointestinal transit monitoring and absorption of theophylline. Int. J. Pharm. 139 (1996) 95-103
27. Rowland M., Riegelman S., and Epstein W.L. Absorption kinetics of griseofulvin in man. J. Pharm. Sci. 57 (1968) 984-989
28. Sunesen V.H., Vedelsdal R., Kristensen H.G., Christrup L., and Müllertz A. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur. J. Pharm. Sci. 24 (2005) 297-303
29. Takamatsu N., Welage L.S., Hayashi Y., Yamamoto R., Barnett J.L., Shah V.P., Lesko L.J., Ramachandran C., and Amidon G.L. Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility. Eur. J. Pharm. Biopharm. 53 (2002) 37-47
30. Tanigawara Y., Yamaoka K., Nakagawa T., and Uno T. Correlation between in vivo mean dissolution time and in vitro mean dissolution time of ampicillin products. J. Pharmacobiodyn. 5 (1982) 370-372
31. Tanigawara Y., Yamaoka K., Nakagawa T., and Uno T. New method for the evaluation of in vitro dissolution time and disintegration time. Chem. Pharm. Bull. 30 (1982) 1088-1090
32. Tozaki H., Fujita T., Odoriba T., Terabe A., Okabe S., Muranishi S., and Yamamoto A. Validation of a pharmacokinetics model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats. J. Pharm. Pharmacol. 51 (1999) 1107-1112
33. Tuleu C., Andrieux C., Boy P., and Chaumell J.C. Gastrointestinal transit of pellets in rats: effect of size and density. Int. J. Pharm. 180 (1999) 123-131
34. Willems M., Quartero A.O., and Numans M.E. How useful is paracetamol absorption as a maker of gastric emptying? A systematic literature study. Dig. Dis. Sci. 46 (2001) 2256-2262
35. Yamaguchi T., Sasaki K., Kurosaki Y., Nakayama T., and Kimura T. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosaalicylic acid. J. Drug Target. 2 (1994) 123-131
36. Yamaoka K., Tanigawara Y., Tanaka H., and Uno Y. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn. 4 (1981) 879-885
37. Yokoe J., Iwasaki N., Haruta S., Kadono K., Ogawara K., Higaki K., and Kimura T. Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. J. Control. Release 86 (2003) 305-313